XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.4
SCHEDULE OF PRO FORMA FINANCIAL INFORMATION (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Preferred Stock authorized 2,000,000           2,000,000   2,000,000
Preferred Stock issued 0           0   0
Common Stock authorized 60,000,000           60,000,000   60,000,000
Common Stock issued 1,898,466           1,898,466   1,877,970
Net Income (Loss) Attributable to Parent $ (6,820,287) $ (5,597,681) $ (4,070,457) $ (4,062,580) $ (4,426,559) $ (2,538,500) $ (16,488,425) $ (11,027,640) $ (15,549,244)
Basic net loss per share $ (3.61)     $ (2.18)     $ (8.74) $ (5.95)  
Diluted net loss per share $ (3.61)     $ (2.18)     $ (8.74) $ (5.95)  
Weighted average common and common equivalent shares, basic 1,890,933     1,861,090     1,886,465 1,851,916  
Weighted average common and common equivalent shares, diluted 1,890,933     1,861,090     1,886,465 1,851,916  
Reverse Stock Split [Member]                  
Preferred Stock authorized                 2,000,000
Preferred Stock authorized, Pro forma                 2,000,000
Preferred Stock issued                 0
Preferred Stock issued, Pro forma                 0
Common Stock authorized                 60,000,000
Common Stock authorized, Pro forma                 60,000,000
Common Stock issued                 46,949,240
Common Stock issued, Pro forma                 1,887,969
Net Loss, Pro forma                 $ (15,549,244)
Basic net loss per share                 $ (0.34)
Diluted net loss per share                 (0.34)
Basic net loss per share, Pro forma                 (8.38)
Diluted net loss per share, Pro forma                 $ (8.38)
Weighted average common and common equivalent shares, basic                 46,399,137
Weighted average common and common equivalent shares, diluted                 46,399,137
Weighted average common and common equivalent shares, basic Pro forma                 1,855,965
Weighted average common and common equivalent shares, diluted Pro forma                 1,855,965